NVAX logo

Novavax, Inc. (NVAX) Selling, General & Administrative Expenses

Annual SG&A:

$0.00-$468.95M(-100.00%)
December 31, 2024

Summary

  • As of today, NVAX annual SG&A is $0.00, with the most recent change of -$468.95 million (-100.00%) on December 31, 2024.
  • During the last 3 years, NVAX annual SG&A has fallen by -$298.36 million (-100.00%).
  • NVAX annual SG&A is now -100.00% below its all-time high of $488.69 million, reached on December 31, 2022.

Performance

NVAX SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Quarterly SG&A:

$31.66M-$11.96M(-27.42%)
September 30, 2025

Summary

  • As of today, NVAX quarterly SG&A is $31.66 million, with the most recent change of -$11.96 million (-27.42%) on September 30, 2025.
  • Over the past year, NVAX quarterly SG&A has dropped by -$39.09 million (-55.26%).
  • NVAX quarterly SG&A is now -80.42% below its all-time high of $161.66 million, reached on December 31, 2022.

Performance

NVAX Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

TTM SG&A:

-$18.47B+$341.75M(+1.82%)
September 30, 2025

Summary

  • As of today, NVAX TTM SG&A is -$18.47 billion, with the most recent change of +$341.75 million (+1.82%) on September 30, 2025.
  • Over the past year, NVAX TTM SG&A has dropped by -$18.88 billion (-4559.82%).
  • NVAX TTM SG&A is now -81976.56% below its all-time high of -$22.50 million.

Performance

NVAX TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

NVAX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-100.0%-55.3%-4559.8%
3Y3 Years-100.0%-74.2%-4590.6%
5Y5 Years-100.0%-44.4%-10000.0%

NVAX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-100.0%at low-80.4%at low-22.7%+6.3%
5Y5-Year-100.0%at low-80.4%at low-203.5%+6.3%
All-TimeAll-Time-100.0%at low-80.4%>+9999.0%>-9999.0%+6.3%

NVAX Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$31.66M(-27.4%)
$201.70M(-16.2%)
Jun 2025
-
$43.61M(-9.3%)
$240.79M(-19.3%)
Mar 2025
-
$48.09M(-38.6%)
$298.48M(-11.5%)
Dec 2024
$0.00(-100.0%)
$78.34M(+10.7%)
$337.19M(-18.6%)
Sep 2024
-
$70.75M(-30.2%)
$414.08M(-8.1%)
Jun 2024
-
$101.30M(+16.7%)
$450.79M(+1.7%)
Mar 2024
-
$86.80M(-44.1%)
$443.21M(-5.5%)
Dec 2023
$468.95M(-4.0%)
$155.24M(+44.5%)
$468.95M(-1.4%)
Sep 2023
-
$107.46M(+14.7%)
$475.37M(-3.1%)
Jun 2023
-
$93.72M(-16.7%)
$490.79M(-2.9%)
Mar 2023
-
$112.53M(-30.4%)
$505.23M(+3.4%)
Dec 2022
$488.69M(+63.8%)
$161.66M(+31.6%)
$488.69M(+18.8%)
Sep 2022
-
$122.88M(+13.6%)
$411.24M(+12.3%)
Jun 2022
-
$108.16M(+12.7%)
$366.16M(+10.6%)
Mar 2022
-
$95.99M(+14.0%)
$331.16M(+11.0%)
Dec 2021
$298.36M(+105.4%)
$84.21M(+8.3%)
$298.36M(+8.3%)
Sep 2021
-
$77.79M(+6.3%)
$275.46M(+8.2%)
Jun 2021
-
$73.16M(+15.8%)
$254.54M(+27.8%)
Mar 2021
-
$63.19M(+3.1%)
$199.10M(+37.0%)
Dec 2020
$145.29M(+322.1%)
$61.31M(+7.8%)
$145.29M(+57.7%)
Sep 2020
-
$56.88M(+221.0%)
$92.16M(+113.4%)
Jun 2020
-
$17.72M(+88.9%)
$43.18M(+23.1%)
Mar 2020
-
$9.38M(+14.6%)
$35.06M(+1.9%)
Dec 2019
$34.42M(+0.0%)
$8.18M(+3.6%)
$34.42M(-2.9%)
Sep 2019
-
$7.90M(-17.8%)
$35.46M(-1.1%)
Jun 2019
-
$9.61M(+10.0%)
$35.87M(+4.0%)
Mar 2019
-
$8.73M(-5.3%)
$34.49M(+0.2%)
Dec 2018
$34.41M(-0.1%)
$9.22M(+11.0%)
$34.41M(+2.0%)
Sep 2018
-
$8.31M(+1.0%)
$33.73M(+0.6%)
Jun 2018
-
$8.22M(-4.9%)
$33.53M(-2.1%)
Mar 2018
-
$8.65M(+1.3%)
$34.25M(-0.6%)
Dec 2017
$34.45M(-26.0%)
$8.54M(+5.2%)
$34.45M(+0.6%)
Sep 2017
-
$8.12M(-9.2%)
$34.25M(-13.7%)
Jun 2017
-
$8.94M(+1.0%)
$39.69M(-11.5%)
Mar 2017
-
$8.85M(+6.1%)
$44.85M(-3.6%)
Dec 2016
$46.53M(+50.9%)
$8.34M(-38.4%)
$46.53M(-1.1%)
Sep 2016
-
$13.56M(-3.9%)
$47.03M(+10.6%)
Jun 2016
-
$14.10M(+33.9%)
$42.54M(+19.7%)
Mar 2016
-
$10.53M(+18.9%)
$35.53M(+15.2%)
Dec 2015
$30.84M(+54.8%)
$8.85M(-2.3%)
$30.84M(+14.0%)
Sep 2015
-
$9.06M(+27.8%)
$27.05M(+18.9%)
Jun 2015
-
$7.09M(+21.3%)
$22.75M(+6.0%)
Mar 2015
-
$5.84M(+15.5%)
$21.46M(+7.7%)
Dec 2014
$19.93M(+34.5%)
$5.06M(+6.3%)
$19.93M(+5.2%)
Sep 2014
-
$4.76M(-18.1%)
$18.95M(+5.0%)
Jun 2014
-
$5.81M(+34.8%)
$18.05M(+11.0%)
Mar 2014
-
$4.31M(+5.6%)
$16.26M(+11.0%)
Dec 2013
$14.82M(+34.9%)
$4.08M(+5.8%)
$14.64M(+10.4%)
Sep 2013
-
$3.86M(-3.9%)
$13.26M(+12.5%)
Jun 2013
-
$4.01M(+48.9%)
$11.78M(+12.9%)
Mar 2013
-
$2.69M(-0.1%)
$10.44M(-5.0%)
Dec 2012
$10.99M(-3.4%)
$2.70M(+13.3%)
$10.99M(+2.3%)
Sep 2012
-
$2.38M(-10.6%)
$10.74M(-3.2%)
Jun 2012
-
$2.66M(-17.9%)
$11.10M(-5.7%)
Mar 2012
-
$3.25M(+32.3%)
$11.77M(+3.5%)
Dec 2011
$11.38M(+5.3%)
$2.45M(-10.4%)
$11.38M(+1.6%)
Sep 2011
-
$2.74M(-18.0%)
$11.20M(-0.9%)
Jun 2011
-
$3.34M(+17.1%)
$11.31M(+1.7%)
Mar 2011
-
$2.85M(+25.2%)
$11.12M(+2.9%)
Dec 2010
$10.80M
$2.28M(-19.9%)
$10.80M(-8.4%)
DateAnnualQuarterlyTTM
Sep 2010
-
$2.84M(-9.7%)
$11.79M(-3.0%)
Jun 2010
-
$3.15M(+24.2%)
$12.16M(+5.1%)
Mar 2010
-
$2.54M(-22.4%)
$11.57M(-3.0%)
Dec 2009
$11.93M(+7.6%)
$3.27M(+1.9%)
$11.93M(+37.7%)
Sep 2009
-
$3.21M(+25.2%)
$8.66M(+28.9%)
Jun 2009
-
$2.56M(-11.4%)
$6.72M(-8.2%)
Mar 2009
-
$2.89M(>+9900.0%)
$7.32M(-4.6%)
Dec 2008
$11.09M(-20.6%)
$0.00(-100.0%)
$7.67M(-27.6%)
Sep 2008
-
$1.26M(-60.0%)
$10.59M(-14.7%)
Jun 2008
-
$3.17M(-2.4%)
$12.41M(-1.6%)
Mar 2008
-
$3.24M(+11.1%)
$12.61M(-9.7%)
Dec 2007
$13.96M(+23.7%)
$2.92M(-5.4%)
$13.96M(+26.4%)
Sep 2007
-
$3.08M(-8.2%)
$11.04M(+5.1%)
Jun 2007
-
$3.36M(-26.9%)
$10.51M(+7.4%)
Mar 2007
-
$4.60M(>+9900.0%)
$9.79M(+23.1%)
Dec 2006
$11.29M(-22.6%)
$0.00(-100.0%)
$7.95M(-20.9%)
Sep 2006
-
$2.55M(-3.3%)
$10.04M(-0.7%)
Jun 2006
-
$2.64M(-4.4%)
$10.11M(-12.9%)
Mar 2006
-
$2.76M(+31.7%)
$11.61M(+5.8%)
Dec 2005
$14.59M(-54.8%)
$2.09M(-20.2%)
$10.97M(-38.8%)
Sep 2005
-
$2.62M(-36.6%)
$17.93M(-31.4%)
Jun 2005
-
$4.14M(+95.0%)
$26.14M(-11.7%)
Mar 2005
-
$2.12M(-76.6%)
$29.62M(+0.3%)
Dec 2004
$32.30M(+105.4%)
$9.05M(-16.4%)
$29.53M(+33.0%)
Sep 2004
-
$10.83M(+42.2%)
$22.20M(+45.3%)
Jun 2004
-
$7.62M(+274.8%)
$15.28M(+34.1%)
Mar 2004
-
$2.03M(+18.3%)
$11.39M(-14.7%)
Dec 2003
$15.72M(-26.9%)
$1.72M(-56.1%)
$13.35M(-15.7%)
Sep 2003
-
$3.91M(+5.0%)
$15.84M(-2.6%)
Jun 2003
-
$3.73M(-6.7%)
$16.27M(-11.1%)
Mar 2003
-
$4.00M(-5.0%)
$18.31M(-14.8%)
Dec 2002
$21.50M(+16.3%)
$4.21M(-3.1%)
$21.50M(+24.3%)
Sep 2002
-
$4.34M(-24.7%)
$17.30M(-2.7%)
Jun 2002
-
$5.77M(-19.8%)
$17.79M(+6.2%)
Mar 2002
-
$7.19M(>+9900.0%)
$16.75M(+28.4%)
Dec 2001
$18.49M(+215.7%)
$0.00(-100.0%)
$13.04M(0.0%)
Sep 2001
-
$4.83M(+2.2%)
$13.04M(+58.8%)
Jun 2001
-
$4.73M(+35.7%)
$8.21M(+135.7%)
Mar 2001
-
$3.48M(>+9900.0%)
$3.48M(>+9900.0%)
Dec 2000
$5.86M(>+9900.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1998
$0.00(0.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 1998
-
$0.00(0.0%)
$500.00K(-54.5%)
Jun 1998
-
$0.00(0.0%)
$1.10M(-35.3%)
Mar 1998
-
$0.00(-100.0%)
$1.70M(-26.1%)
Dec 1997
$0.00(0.0%)
$500.00K(-16.7%)
$2.30M(-4.2%)
Sep 1997
-
$600.00K(0.0%)
$2.40M(+14.3%)
Jun 1997
-
$600.00K(0.0%)
$2.10M(+5.0%)
Mar 1997
-
$600.00K(0.0%)
$2.00M(+11.1%)
Dec 1996
$0.00(0.0%)
$600.00K(+100.0%)
$1.80M(+50.0%)
Sep 1996
-
$300.00K(-40.0%)
$1.20M(+33.3%)
Jun 1996
-
$500.00K(+25.0%)
$900.00K(+125.0%)
Mar 1996
-
$400.00K
$400.00K
Dec 1995
$0.00
-
-

FAQ

  • What is Novavax, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Novavax, Inc.?
  • What is Novavax, Inc. annual SG&A year-on-year change?
  • What is Novavax, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Novavax, Inc.?
  • What is Novavax, Inc. quarterly SG&A year-on-year change?
  • What is Novavax, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Novavax, Inc.?
  • What is Novavax, Inc. TTM SG&A year-on-year change?

What is Novavax, Inc. annual SG&A?

The current annual SG&A of NVAX is $0.00

What is the all-time high annual SG&A for Novavax, Inc.?

Novavax, Inc. all-time high annual SG&A is $488.69M

What is Novavax, Inc. annual SG&A year-on-year change?

Over the past year, NVAX annual SG&A has changed by -$468.95M (-100.00%)

What is Novavax, Inc. quarterly SG&A?

The current quarterly SG&A of NVAX is $31.66M

What is the all-time high quarterly SG&A for Novavax, Inc.?

Novavax, Inc. all-time high quarterly SG&A is $161.66M

What is Novavax, Inc. quarterly SG&A year-on-year change?

Over the past year, NVAX quarterly SG&A has changed by -$39.09M (-55.26%)

What is Novavax, Inc. TTM SG&A?

The current TTM SG&A of NVAX is -$18.47B

What is the all-time high TTM SG&A for Novavax, Inc.?

Novavax, Inc. all-time high TTM SG&A is -$22.50M

What is Novavax, Inc. TTM SG&A year-on-year change?

Over the past year, NVAX TTM SG&A has changed by -$18.88B (-4559.82%)
On this page